Healthcare provider profile · identity verified

Lance Gator Gault, D.O.

Family Practice · CLOVIS, CA · NPI 1164615811

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	660	228
Amlodipine Besylate	Amlodipine Besylate	486	170
Lisinopril	Lisinopril	399	130
Losartan Potassium	Losartan Potassium	331	111
Levothyroxine Sodium	Levothyroxine Sodium	290	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	263	50
Famotidine	Famotidine	228	89
Metformin Hcl	Metformin Hcl	227	82
Pantoprazole Sodium	Pantoprazole Sodium	216	77
Rosuvastatin Calcium	Rosuvastatin Calcium	215	68
Albuterol Sulfate Hfa	Albuterol Sulfate	198	76
Metoprolol Tartrate	Metoprolol Tartrate	166	53
Glipizide	Glipizide	153	48
Tamsulosin Hcl	Tamsulosin Hcl	151	61
Atenolol	Atenolol	132	46
Metformin Hcl Er	Metformin Hcl	121	45
Gabapentin	Gabapentin	120	46
Ozempic	Semaglutide	111	17
Chlorthalidone	Chlorthalidone	108	42
Trazodone Hcl	Trazodone Hcl	108	42
Ibuprofen	Ibuprofen	97	42
Metoprolol Succinate	Metoprolol Succinate	97	35
Alvesco	Ciclesonide	95	36
Furosemide	Furosemide	95	42
Lorazepam	Lorazepam	89	20
Allopurinol	Allopurinol	88	32
Doxycycline Monohydrate	Doxycycline Monohydrate	85	67
Simvastatin	Simvastatin	81	30
Jardiance	Empagliflozin	80	32
Omeprazole	Omeprazole	80	25
Tizanidine Hcl	Tizanidine Hcl	80	44
Alendronate Sodium	Alendronate Sodium	79	26
Azelastine Hcl	Azelastine Hcl	79	34
Clopidogrel	Clopidogrel Bisulfate	79	24
Fluticasone Propionate	Fluticasone Propionate	78	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	26
Prednisone	Prednisone	76	55
Tramadol Hcl	Tramadol Hcl	76	12
Potassium Chloride	Potassium Chloride	75	29
Humulin N	Insulin Nph Human Isophane	71	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	suppressed
Finasteride	Finasteride	68	22
Duloxetine Hcl	Duloxetine Hcl	67	25
Temazepam	Temazepam	67	11
Hydralazine Hcl	Hydralazine Hcl	66	23
Montelukast Sodium	Montelukast Sodium	63	19
Hydrochlorothiazide	Hydrochlorothiazide	62	24
Carvedilol	Carvedilol	61	22
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	57	21
Terazosin Hcl	Terazosin Hcl	56	20
Meloxicam	Meloxicam	55	19
Lactulose	Lactulose	50	18
Tadalafil	Tadalafil	50	suppressed
Ondansetron Odt	Ondansetron	49	18
Cefadroxil	Cefadroxil	47	41
Colchicine	Colchicine	47	14
Humulin N Kwikpen	Insulin Nph Human Isophane	47	16
Breyna	Budesonide/Formoterol Fumarate	46	21
Humulin R	Insulin Regular, Human	45	15
Sertraline Hcl	Sertraline Hcl	42	14
Bupropion Xl	Bupropion Hcl	40	12
Triamcinolone Acetonide	Triamcinolone Acetonide	38	21
Acyclovir	Acyclovir	36	14
Pregabalin	Pregabalin	34	11
Clonazepam	Clonazepam	33	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	32	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	31
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	24
Pravastatin Sodium	Pravastatin Sodium	30	12
Wixela Inhub	Fluticasone Propion/Salmeterol	30	15
Spiriva Respimat	Tiotropium Bromide	29	13
Fluoxetine Hcl	Fluoxetine Hcl	28	11
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	14
Propranolol Hcl	Propranolol Hcl	26	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Azithromycin	Azithromycin	25	23
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fluocinonide	Fluocinonide	25	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	suppressed
Trospium Chloride	Trospium Chloride	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Naproxen	Naproxen	22	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	22	suppressed
Baclofen	Baclofen	21	suppressed
Betamethasone Valerate	Betamethasone Valerate	21	15
Glimepiride	Glimepiride	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Topiramate	Topiramate	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Estradiol	Estradiol	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluorouracil	Fluorouracil	15	14
Spironolactone	Spironolactone	14	suppressed
Victoza 2-Pak	Liraglutide	14	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	12	11
Methocarbamol	Methocarbamol	12	suppressed
Oxaprozin	Oxaprozin	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cromolyn Sodium	Cromolyn Sodium	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nitroglycerin	Nitroglycerin	11	11
Ofloxacin	Ofloxacin	11	11
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error